244 related articles for article (PubMed ID: 19292980)
1. Telmisartan, an angiotensin II type 1 receptor antagonist, attenuates T-type Ca2+ channel expression in neonatal rat cardiomyocytes.
Morishima M; Wang Y; Akiyoshi Y; Miyamoto S; Ono K
Eur J Pharmacol; 2009 May; 609(1-3):105-12. PubMed ID: 19292980
[TBL] [Abstract][Full Text] [Related]
2. 17 beta-estradiol modulates expression of low-voltage-activated Ca(V)3.2 T-type calcium channel via extracellularly regulated kinase pathway in cardiomyocytes.
Marni F; Wang Y; Morishima M; Shimaoka T; Uchino T; Zheng M; Kaku T; Ono K
Endocrinology; 2009 Feb; 150(2):879-88. PubMed ID: 18832095
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
Wang WW; Zhang FL; Chen JH; Chen XH; Fu FY; Tang MR; Chen LL
Can J Physiol Pharmacol; 2015 Aug; 93(8):657-65. PubMed ID: 26158699
[TBL] [Abstract][Full Text] [Related]
4. Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARγ activation.
Chen HY; Xu Z; Chen LF; Wang W; Fang Q; Yan XW
J Cardiovasc Pharmacol; 2012 Jun; 59(6):570-5. PubMed ID: 22392065
[TBL] [Abstract][Full Text] [Related]
5. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels.
Ferron L; Capuano V; Ruchon Y; Deroubaix E; Coulombe A; Renaud JF
Circ Res; 2003 Dec; 93(12):1241-8. PubMed ID: 14615287
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
Chen K; Mehta JL; Li D; Joseph L; Joseph J
Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 stimulates the expression of L-type Ca2+ channels in neonatal rat cardiomyocytes via the extracellular signal-regulated kinase 1/2 pathway.
Yu L; Li M; She T; Shi C; Meng W; Wang B; Cheng M
J Membr Biol; 2013 Apr; 246(4):343-53. PubMed ID: 23546014
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan but not valsartan inhibits TGF-beta-mediated accumulation of extracellular matrix via activation of PPARgamma.
Yao Y; Zou R; Liu X; Jiang J; Huang Q; He Y; Li M; Wang S; Zhou J; Ma D; Xu G
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):543-8. PubMed ID: 18846335
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity.
Mori Y; Itoh Y; Tajima N
Am J Hypertens; 2007 Apr; 20(4):431-6. PubMed ID: 17386352
[TBL] [Abstract][Full Text] [Related]
12. Internalization of constitutively active N111G MUTANT of AT1 receptor induced by angiotensin II-receptor antagonists candesartan, losartan, and telmisartan: comparison with valsartan.
Bhuiyan MA; Hossain M; Nakamura T; Ozaki M; Nagatomo T
J Pharmacol Sci; 2010; 112(4):459-62. PubMed ID: 20308802
[TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor activates cardiac L-Type Ca2+ channels via phosphorylation of serine 1829 in the rabbit Cav1.2 subunit.
Takahashi E; Fukuda K; Miyoshi S; Murata M; Kato T; Ita M; Tanabe T; Ogawa S
Circ Res; 2004 May; 94(9):1242-8. PubMed ID: 15044319
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina.
Kurihara T; Ozawa Y; Nagai N; Shinoda K; Noda K; Imamura Y; Tsubota K; Okano H; Oike Y; Ishida S
Diabetes; 2008 Aug; 57(8):2191-8. PubMed ID: 18487452
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
Montón M; Jiménez A; Núñez A; López-Blaya A; Farré J; Gómez J; Zalba LR; Sánchez de Miguel L; Casado S; López-Farré A
J Cardiovasc Pharmacol; 2000 Jun; 35(6):906-13. PubMed ID: 10836725
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes.
Lalevée N; Rebsamen MC; Barrère-Lemaire S; Perrier E; Nargeot J; Bénitah JP; Rossier MF
Cardiovasc Res; 2005 Aug; 67(2):216-24. PubMed ID: 15919070
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 rat.
DeMarco VG; Johnson MS; Habibi J; Pulakat L; Gul R; Hayden MR; Tilmon RD; Dellsperger KC; Winer N; Whaley-Connell AT; Sowers JR
Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H181-90. PubMed ID: 21057043
[TBL] [Abstract][Full Text] [Related]
18. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.
Benson SC; Pershadsingh HA; Ho CI; Chittiboyina A; Desai P; Pravenec M; Qi N; Wang J; Avery MA; Kurtz TW
Hypertension; 2004 May; 43(5):993-1002. PubMed ID: 15007034
[TBL] [Abstract][Full Text] [Related]
19. Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation.
Hilfiker-Kleiner D; Kaminski K; Kaminska A; Fuchs M; Klein G; Podewski E; Grote K; Kiian I; Wollert KC; Hilfiker A; Drexler H
Circulation; 2004 May; 109(18):2227-33. PubMed ID: 15117851
[TBL] [Abstract][Full Text] [Related]
20. The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action.
Kim HK; Youm JB; Lee SR; Lim SE; Lee SY; Ko TH; Long le T; Nilius B; Won du N; Noh JH; Ko KS; Rhee BD; Kim N; Han J
Pflugers Arch; 2012 Dec; 464(6):631-43. PubMed ID: 23073892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
